Related Experiment Video
Updated: Jul 19, 2026
14:54
Rat Model of Photochemically-Induced Posterior Ischemic Optic Neuropathy
Published on: November 29, 2015
[Ischemic optic neuropathy. Pathogenesis, clinical features, diagnostics and treatment].
Iwona Obuchowska1, Zofia Mariak
1Kliniki Okulistyki Akademii Medycznej w Białymstoku.
Klinika Oczna
|October 6, 2006
Summary
Anterior ischemic optic neuropathy (AION) is a common cause of vision loss in older adults, often linked to hypertension and diabetes. Posterior ischemic optic neuropathy (PION) is rare and presents differently, with normal optic disc appearance.
Area of Science:
- Ophthalmology
- Neurology
- Vascular Medicine
Context:
- Ischemic optic neuropathy (ION) is a significant cause of vision impairment, particularly in elderly individuals.
- ION is categorized into anterior (AION) and posterior (PION) types based on lesion location.
- AION involves the optic nerve head, while PION affects the retrobulbar optic nerve.
Purpose:
- To elucidate the characteristics, risk factors, and clinical presentation of anterior ischemic optic neuropathy (AION).
- To differentiate AION from the rarer posterior ischemic optic neuropathy (PION).
- To provide a comprehensive overview of AION and PION subtypes.
Summary:
- Anterior ischemic optic neuropathy (AION) results from impaired blood flow to the optic nerve head, with key risk factors including hypertension, diabetes, and atherosclerosis.
- AION symptoms include sudden, painless vision loss, optic disc edema, and characteristic visual field defects.
- Posterior ischemic optic neuropathy (PION) is rare, diagnosed after excluding other causes, and presents with acute visual loss and a normal optic disc; subtypes include perioperative, arteritic, and nonarteritic.
Impact:
- Improved understanding of AION and PION aids in accurate diagnosis and management of optic neuropathies.
- Highlights the importance of managing vascular risk factors to prevent AION.
- Contributes to the clinical knowledge base for visual impairment in the aging population.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:15Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...